Literature DB >> 7535796

Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

V Fiorelli1, R Gendelman, F Samaniego, P D Markham, B Ensoli.   

Abstract

Kaposi's sarcoma (KS) is a proliferative disease of vascular origin particularly frequent in HIV-1-infected homosexual men (AIDS-KS) and characterized by proliferating spindle-shaped cells, angiogenesis, and inflammatory cell infiltration. Previous work has suggested that KS spindle cells are of endothelial cell origin and that chronic immune activation via the release of inflammatory cytokines may cooperate with basic fibroblast growth factor (bFGF) and the HIV-1 Tat protein in the induction and progression of AIDS-KS. Here we show that KS spindle cells have features of activated endothelial cells, and that conditioned media from activated T cells, rich in the same inflammatory cytokines increased in HIV-1-infected individuals, induce normal endothelial cells to acquire the phenotypic and functional features of KS cells. These include (a) acquisition of a similar pattern of cell surface antigen expression; (b) similar proliferative response to bFGF; (c) induction of the responsiveness to the mitogenic effect of extracellular HIV-1 Tat protein that is now able to promote the G1-S transition of endothelial cell cycle; and (d) induction in nude mice of vascular lesions closely resembling early KS as well as the lesions induced by inoculation of KS cells. These results suggest that chronic immune activation, via release of inflammatory cytokines, may play a role in the induction of KS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535796      PMCID: PMC295689          DOI: 10.1172/JCI117849

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  72 in total

1.  AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.

Authors:  P A Scully; H K Steinman; C Kennedy; K Trueblood; D M Frisman; J R Voland
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 2.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions.

Authors:  Z Ruszczak; A Mayer-Da Silva; C E Orfanos
Journal:  Am J Dermatopathol       Date:  1987-10       Impact factor: 1.533

4.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

Authors:  S Nakamura; S Z Salahuddin; P Biberfeld; B Ensoli; P D Markham; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

5.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

6.  Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization.

Authors:  L Xerri; J Hassoun; J Planche; V Guigou; J J Grob; P Parc; D Birnbaum; O deLapeyriere
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

7.  Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals.

Authors:  A Vyakarnam; P Matear; A Meager; G Kelly; B Stanley; I Weller; P Beverley
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  Idiopathic production of interleukin-1 in acquired immune deficiency syndrome.

Authors:  J L Lepe-Zuniga; P W Mansell; E M Hersh
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

9.  Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

Authors:  S Z Salahuddin; S Nakamura; P Biberfeld; M H Kaplan; P D Markham; L Larsson; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

10.  Cutaneous and plasma values of von Willebrand factor in AIDS: a marker of endothelial stimulation?

Authors:  M Janier; B Flageul; L Drouet; M L Scrobohaci; J M Villette; A Palangie; F Cottenot
Journal:  J Invest Dermatol       Date:  1988-05       Impact factor: 8.551

View more
  41 in total

1.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.

Authors:  S Mitola; R Soldi; I Zanon; L Barra; M I Gutierrez; B Berkhout; M Giacca; F Bussolino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.

Authors:  V Modur; M J Feldhaus; A S Weyrich; D L Jicha; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.

Authors:  Elena Toschi; Ilaria Bacigalupo; Raffaele Strippoli; Chiara Chiozzini; Anna Cereseto; Mario Falchi; Filomena Nappi; Cecilia Sgadari; Giovanni Barillari; Fabrizio Mainiero; Barbara Ensoli
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

5.  Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  Virology       Date:  2011-02-25       Impact factor: 3.616

6.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice.

Authors:  Xiuying Chen; Lin Cheng; Xuemei Jia; Yi Zeng; Shuihong Yao; Zhigang Lv; Di Qin; Xin Fang; Yongliang Lei; Chun Lu
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Authors:  F Samaniego; P D Markham; R Gendelman; Y Watanabe; V Kao; K Kowalski; J A Sonnabend; A Pintus; R C Gallo; B Ensoli
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.

Authors:  R K Ganju; N Munshi; B C Nair; Z Y Liu; P Gill; J E Groopman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.

Authors:  C B Morris; R Gendelman; A J Marrogi; M Lu; J M Lockyer; W Alperin-Lea; B Ensoli
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.